Redefining Alzheimer’s diagnostics with blood-based biomarkers

Join Tecan for an in-depth look at the future of CNS biomarker testing - from tackling the challenges of blood-based detection to exploring the latest breakthroughs in Alzheimer’s research. Learn how innovative strategies and Tecan’s technologies can support and accelerate your work.

Webinar overview

  1. Advancing CNS biomarker detection in blood
    • Challenges in measuring CNS biomarkers in blood
      • Blood-brain barrier dysfunction & passage
      • Blood as a testing matrix: limitations and advantages for CNS biomarker testing
    • How immunoprecipitation can improve CNS biomarker detection
    • Study data and findings
  2. Brain-derived Tau: a breakthrough in Alzheimer’s blood testing
    • BD-Tau biology
    • Advantages over other isoforms
    • Study data and findings
  3. Tecan solutions to keep your research at the forefront.

Speakers

  1. Oliver Schmidt, Product Manager, Tecan
  2. Prof. Dr. Jens Wiltfang, Clinical director of the Department of Psychiatry & Psychotherapy, University Medical Center (UMC) Göttingen
  3. Dr. Ingolf Lachmann, CEO of Roboscreen GmbH
  4. Fernando Gonzalez-Ortiz, Medical Doctor/ Master’s in Science/ PhD candidate

Catch up on every detail - now available on demand.

Other Webinars from IBL International GmbH, Part of Tecan Group

Life Science Webinars by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.